1,306 Shares in Penumbra, Inc. (NYSE:PEN) Purchased by Virtu Financial LLC

Virtu Financial LLC purchased a new position in Penumbra, Inc. (NYSE:PEN - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 1,306 shares of the company's stock, valued at approximately $349,000.

Several other institutional investors have also modified their holdings of PEN. JPMorgan Chase & Co. lifted its stake in shares of Penumbra by 437.0% in the first quarter. JPMorgan Chase & Co. now owns 703,634 shares of the company's stock worth $188,159,000 after acquiring an additional 572,606 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Penumbra by 47.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 707,061 shares of the company's stock valued at $167,913,000 after buying an additional 227,506 shares in the last quarter. GAMMA Investing LLC raised its stake in Penumbra by 42,409.9% during the first quarter. GAMMA Investing LLC now owns 189,594 shares of the company's stock valued at $50,699,000 after buying an additional 189,148 shares in the last quarter. Los Angeles Capital Management LLC raised its stake in Penumbra by 487.1% during the first quarter. Los Angeles Capital Management LLC now owns 179,550 shares of the company's stock valued at $48,013,000 after buying an additional 148,968 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in Penumbra during the fourth quarter valued at approximately $23,866,000. Institutional investors and hedge funds own 88.88% of the company's stock.

Penumbra Stock Performance

Shares of PEN stock opened at $253.19 on Friday. Penumbra, Inc. has a 12-month low of $184.19 and a 12-month high of $310.00. The firm has a market capitalization of $9.87 billion, a price-to-earnings ratio of 67.34, a price-to-earnings-growth ratio of 2.31 and a beta of 0.40. The business has a 50 day simple moving average of $246.16 and a 200 day simple moving average of $265.74. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.75 and a quick ratio of 4.04.

Penumbra (NYSE:PEN - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.05. Penumbra had a return on equity of 11.55% and a net margin of 11.54%. The business had revenue of $339.46 million during the quarter, compared to analyst estimates of $327.37 million. During the same period in the prior year, the company posted $0.64 EPS. The business's revenue for the quarter was up 13.4% compared to the same quarter last year. On average, equities research analysts anticipate that Penumbra, Inc. will post 3.67 EPS for the current year.

Analyst Ratings Changes

PEN has been the topic of several research reports. Morgan Stanley upped their price objective on Penumbra from $260.00 to $266.00 and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Truist Financial set a $310.00 price objective on Penumbra and gave the company a "buy" rating in a research note on Wednesday, July 30th. William Blair upgraded Penumbra to a "strong-buy" rating in a research note on Friday, July 18th. Robert W. Baird upped their price objective on Penumbra from $283.00 to $285.00 and gave the company an "outperform" rating in a research note on Wednesday, July 30th. Finally, Royal Bank Of Canada cut their price objective on Penumbra from $330.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $300.47.

Insider Buying and Selling at Penumbra

In other Penumbra news, EVP Johanna Roberts sold 600 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $258.17, for a total transaction of $154,902.00. Following the completion of the transaction, the executive vice president directly owned 64,714 shares of the company's stock, valued at approximately $16,707,213.38. This trade represents a 0.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Thomas Wilder sold 372 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $240.16, for a total value of $89,339.52. Following the transaction, the director directly owned 372 shares of the company's stock, valued at approximately $89,339.52. The trade was a 50.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 98,487 shares of company stock valued at $24,461,787. 4.20% of the stock is owned by corporate insiders.

Penumbra Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra, Inc. (NYSE:PEN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.